Patents Assigned to Protia, LLC
  • DEUTERIUM-ENRICHED LOSARTAN
    Publication number: 20090076104
    Abstract: The present application describes deuterium-enriched losartan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED VALACYCLOVIR
    Publication number: 20090076039
    Abstract: The present application describes deuterium-enriched valacyclovir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED METHYLPHENIDATE
    Publication number: 20090076079
    Abstract: The present application describes deuterium-enriched methylphenidate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 10, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ROSIGLITAZONE
    Publication number: 20090076093
    Abstract: The present application describes deuterium-enriched rosiglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED AMOXICILIN
    Publication number: 20090075965
    Abstract: The present application describes deuterium-enriched amoxicilin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 19, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED RADAFAXINE
    Publication number: 20090075994
    Abstract: The present application describes deuterium-enriched radafaxine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED PANTOPRAZOLE
    Publication number: 20090076089
    Abstract: The present application describes deuterium-enriched pantoprazole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W Czarnik
  • DEUTERIUM-ENRICHED DECITABINE
    Publication number: 20090075920
    Abstract: The present application describes deuterium-enriched decitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 19, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TEMSIROLIMUS
    Publication number: 20090076060
    Abstract: The present application describes deuterium-enriched temsirolimus, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ERLOTINIB
    Publication number: 20090076042
    Abstract: The present application describes deuterium-enriched erlotinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MK0974
    Publication number: 20090075977
    Abstract: The present application describes deuterium-enriched MK-0974, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ROPINIROLE
    Publication number: 20090076124
    Abstract: The present application describes deuterium-enriched ropinirole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SIMVASTATIN
    Publication number: 20090076134
    Abstract: The present application describes deuterium-enriched simvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED EPLIVANSERIN
    Publication number: 20090076159
    Abstract: The present application describes deuterium-enriched eplivanserin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED VINFLUNINE
    Publication number: 20090076055
    Abstract: The present application describes deuterium-enriched vinflunine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED BORTEZOMIB
    Publication number: 20090076031
    Abstract: The present application describes deuterium-enriched bortezomib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED RANOLAZINE
    Publication number: 20090076018
    Abstract: The present application describes deuterium-enriched ranolazine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MURAGLITAZAR
    Publication number: 20090076102
    Abstract: The present application describes deuterium-enriched muraglitazar, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 19, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED LAMOTRIGINE
    Publication number: 20090076010
    Abstract: The present application describes deuterium-enriched lamotrigine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 5, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MYCOPHENOLATE MOFETIL
    Publication number: 20090076000
    Abstract: The present application describes deuterium-enriched mycophenolate mofetil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 10, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik